June 14, 2013
Nippon Shinyaku announced on June 12 that Taejoon Pharm of South Korea, a licensee of the company’s gastritis and gastric ulcer treatment Gaslon N (irsogladine maleate), launched on the same day Gaslon N-OD Tablets 2 mg, an orodispersible dosage form,...read more